Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Change in Receivables (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Change in Receivables for 17 consecutive years, with -$19.0 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 86.71% to -$19.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $295.0 million through Dec 2025, up 211.74% year-over-year, with the annual reading at $295.0 million for FY2025, 211.74% up from the prior year.
  • Change in Receivables for Q4 2025 was -$19.0 million at Bristol Myers Squibb, up from -$155.0 million in the prior quarter.
  • The five-year high for Change in Receivables was $1.0 billion in Q2 2024, with the low at -$786.0 million in Q1 2022.
  • Average Change in Receivables over 5 years is $137.2 million, with a median of $137.0 million recorded in 2021.
  • The sharpest move saw Change in Receivables plummeted 1073.13% in 2022, then skyrocketed 1467.69% in 2024.
  • Over 5 years, Change in Receivables stood at $168.0 million in 2021, then tumbled by 36.9% to $106.0 million in 2022, then soared by 379.25% to $508.0 million in 2023, then plummeted by 128.15% to -$143.0 million in 2024, then skyrocketed by 86.71% to -$19.0 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$19.0 million, -$155.0 million, and $484.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.